Loading chat...
MN HF2906
Bill
Status
3/27/2025
Primary Sponsor
Andrew Smith
Click for details
AI Summary
-
Establishes a psilocybin therapeutic use program administered by the Commissioner of Health for Minnesota residents age 21+ diagnosed with qualifying medical conditions including PTSD, depression, substance use disorders, anxiety, and chronic pain
-
Requires patients to obtain physician certification, complete health screenings for contraindications, sign informed consent, and register with the state; registration valid for 12 months with annual renewal fees
-
Creates licensing framework for registered facilitators (must be licensed mental health professionals), registered suppliers who cultivate psilocybin in secure facilities, and testing facilities; initial program limited to 20-50 facilitators and no more than 1,000 patients in first three years
-
Reclassifies psilocybin and psilocin from Schedule I to Schedule IV controlled substances under Minnesota law, enabling legal therapeutic use within the regulated program
-
Provides civil and criminal protections for program participants, prohibiting employment discrimination, housing discrimination, and custody denial based solely on lawful program participation; establishes a Psychedelic Medicine Advisory Committee to advise the commissioner
Legislative Description
Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.
Last Action
Committee report, to adopt as amended and re-refer to Commerce Finance and Policy
3/16/2026